- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
On Wednesday Biogen (BIIB) is projected to post third-quarter earnings and revenue that have improved from a year ago.
Consumer tech giants, medical device makers, Big Pharma and health insurers are all angling to profit from the $3 trillion-plus U.S. healthcare market, but security is a major concern.
Wall Street enters the thick of earnings reporting in week three of the season with heavyweights Apple and Alphabet on tap.